AT1 3.85% 2.5¢ atomo diagnostics limited

Media Update, page-434

  1. 1,209 Posts.
    lightbulb Created with Sketch. 646
    @Hippie
    No need to apologise. its all good data - AccessBio is a significant partner for AT1 so their company health + expansion (or lack of) is important to monitor for our investment here.

    And the ann phrase "...line of products granted EUA" should cover the joint AccBio-AT1 Ab test also, as that is also branded 'Carestart Ez ..'..so this should be a positive for AT1 device sales into AccBio Ab tests...lets hope they are able to move >2m devices in 2021

    @dabz
    No, the AccBio Ag test is a nasal swab test. AT1's device has been combined for use in the AccBio Ab test (which is a blood based antibody test). But yes, as per above, the additional 'line of products' covered under the Carestart brand should cover this test as its in the same suite.

    Last edited by FinFree101: 01/07/21
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.5¢
Change
-0.001(3.85%)
Mkt cap ! $15.98M
Open High Low Value Volume
2.6¢ 2.6¢ 2.5¢ $15.57K 604.4K

Buyers (Bids)

No. Vol. Price($)
4 277067 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 18145 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.